No. | Title | Date | View |
---|---|---|---|
53 | 2023-06-02 | 28 | |
52 | 2023-06-02 | 29 | |
51 | 2023-05-09 | 183 | |
50 | 2023-03-28 | 656 | |
49 | 2023-03-27 | 687 | |
48 | 2022-11-28 | 1095 | |
47 |
OliX Announces Positive Preclinical Data in NASH Non-human Primate Models
|
2022-11-10 | 704 |
46 |
OliX Receives IND Approval from FDA to Develop RNAi Therapeutic OLX10212 for AMD
|
2022-08-08 | 1302 |
45 | 2022-07-05 | 1251 | |
44 | 2022-07-05 | 1061 | |
43 | 2022-06-13 | 1150 | |
42 | 2022-06-07 | 1322 | |
41 | 2022-05-27 | 2053 | |
40 | 2022-05-27 | 1106 | |
39 | 2022-04-12 | 1608 | |
38 |
OliX Pharmaceuticals to Participate in BIO-Europe Spring®
|
2022-03-24 | 1417 |
37 | 2022-03-22 | 1706 | |
36 |
OliX Pharmaceuticals to Present at SMi 13th Annual RNA Therapeutics Conference
|
2022-03-22 | 1298 |
35 | 2022-03-22 | 1109 | |
34 |
OliX Pharmaceuticals Subsidiary mCureX Strengthens Scientific Advisory Board
|
2022-03-22 | 1050 |
- Home
- PR